BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30482749)

  • 1. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
    Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
    BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
    Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
    BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation.
    Weller D; Vedsted P; Anandan C; Zalounina A; Fourkala EO; Desai R; Liston W; Jensen H; Barisic A; Gavin A; Grunfeld E; Lambe M; Law RJ; Malmberg M; Neal RD; Kalsi J; Turner D; White V; Bomb M; Menon U;
    BMJ Open; 2016 Jul; 6(7):e009641. PubMed ID: 27456325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data.
    Vedsted P; Weller D; Zalounina Falborg A; Jensen H; Kalsi J; Brewster D; Lin Y; Gavin A; Barisic A; Grunfeld E; Lambe M; Malmberg M; Turner D; Harland E; Hawryluk B; Law RJ; Neal RD; White V; Bergin R; Harrison S; Menon U; ;
    BMJ Open; 2022 Dec; 12(12):e059669. PubMed ID: 36521881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
    Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
    BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced-stage cancer and time to diagnosis: An International Cancer Benchmarking Partnership (ICBP) cross-sectional study.
    Tørring ML; Falborg AZ; Jensen H; Neal RD; Weller D; Reguilon I; ; Menon U; Vedsted P
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13100. PubMed ID: 31119836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
    Menon U; Weller D; Falborg AZ; Jensen H; Butler J; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Fourkala EO; Gavin AT; Grunfeld E; Harland E; Kalsi J; Law RJ; Lin Y; Turner D; Neal RD; White V; Harrison S; Reguilon I; Lynch C; Vedsted P;
    Br J Cancer; 2022 Sep; 127(5):844-854. PubMed ID: 35618787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathway to diagnosis and treatment for surgically managed lung cancer patients.
    White V; Bergin RJ; Thomas RJ; Whitfield K; Weller D
    Fam Pract; 2020 Mar; 37(2):234-241. PubMed ID: 31665265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries.
    Tørring ML; Murchie P; Hamilton W; Vedsted P; Esteva M; Lautrup M; Winget M; Rubin G
    Br J Cancer; 2017 Sep; 117(6):888-897. PubMed ID: 28787432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
    McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
    Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
    Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
    Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007.
    Maringe C; Walters S; Rachet B; Butler J; Fields T; Finan P; Maxwell R; Nedrebø B; Påhlman L; Sjövall A; Spigelman A; Engholm G; Gavin A; Gjerstorff ML; Hatcher J; Johannesen TB; Morris E; McGahan CE; Tracey E; Turner D; Richards MA; Coleman MP;
    Acta Oncol; 2013 Jun; 52(5):919-32. PubMed ID: 23581611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rural-Urban Disparities in Time to Diagnosis and Treatment for Colorectal and Breast Cancer.
    Bergin RJ; Emery J; Bollard RC; Falborg AZ; Jensen H; Weller D; Menon U; Vedsted P; Thomas RJ; Whitfield K; White V
    Cancer Epidemiol Biomarkers Prev; 2018 Sep; 27(9):1036-1046. PubMed ID: 29987098
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
    Eden M; Harrison S; Griffin M; Lambe M; Pettersson D; Gavin A; Brewster DH; Lin Y; Johannesen TB; Milne RL; Farrugia H; Nishri D; King MJ; Huws DW; Warlow J; Turner D; Earle CC; Peake M; Rashbass J
    Cancer Epidemiol; 2019 Feb; 58():184-192. PubMed ID: 30639877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do perceived barriers to clinical presentation affect anticipated time to presenting with cancer symptoms: an ICBP study.
    Donnelly C; Quaife S; Forbes L; Boylan J; Tishelman C; Gavin A
    Eur J Public Health; 2017 Oct; 27(5):808-813. PubMed ID: 28957476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership.
    Walters S; Maringe C; Butler J; Brierley JD; Rachet B; Coleman MP
    Int J Cancer; 2013 Feb; 132(3):676-85. PubMed ID: 22623157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
    Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
    Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?
    Forbes LJ; Simon AE; Warburton F; Boniface D; Brain KE; Dessaix A; Donnelly C; Haynes K; Hvidberg L; Lagerlund M; Lockwood G; Tishelman C; Vedsted P; Vigmostad MN; Ramirez AJ; Wardle J;
    Br J Cancer; 2013 Feb; 108(2):292-300. PubMed ID: 23370208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with mode of colorectal cancer detection and time to diagnosis: a population level study.
    Sikdar KC; Dickinson J; Winget M
    BMC Health Serv Res; 2017 Jan; 17(1):7. PubMed ID: 28056946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.
    Butler J; Foot C; Bomb M; Hiom S; Coleman M; Bryant H; Vedsted P; Hanson J; Richards M;
    Health Policy; 2013 Sep; 112(1-2):148-55. PubMed ID: 23693117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.